Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is NuroTone Medical's primary focus?
- NuroTone Medical is developing an optical cochlear implant that uses precise light stimulation of cochlear neurons to improve hearing capabilities.
- What problem does NuroTone Medical aim to solve with its technology?
- NuroTone Medical aims to overcome the inherent limitations of existing basic cochlear implant technology by using laser stimulation to improve speech recognition, music perception, and reduce sensitivity to environmental noise.
- When was NuroTone Medical founded?
- NuroTone Medical was founded in September 2018.
- What is the current operational status of NuroTone Medical?
- NuroTone Medical is currently inactive, having ceased operations in December 2025.
- Where is NuroTone Medical headquartered?
- NuroTone Medical is headquartered in Rosh Haayin, Center District, Israel.
- What is NuroTone Medical's current funding stage?
- NuroTone Medical is in the Pre-Funding stage.
- How many employees did NuroTone Medical have?
- NuroTone Medical had 4 employees.
- Who are the founders of NuroTone Medical?
- The founders of NuroTone Medical are Yossi Bornstein, Danny Albeck, and Prof. Claus Richter.